# FDA Advisory Panel Votes to Loosen Rules on BPC-157, TB-500, and MOTS-C Despite Agency Scientists' Opposition - Medical Daily

*Источник: Medical Daily*
*Дата: 2026-07-24*
*Язык: en*

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNUFZrM2hpdXdFeEdLUER6SzlLUmdXVTU0SHV6clQ3XzNORjdpSjdHRFNuMEFucmJKRmY2VzBkVkd5dlVkaGJQZlRhVXd4RmttazNlTUoxQU1DV1hJcTdYU2lCazZOUjRJSHY4c3ZVQ3JrMElTNkliTFpYSWJqNjZrelh3cDEwRTNQZ0lyNzdmQnZrTzdrNUtqaUpjZWhFOXpmdzVN?oc=5" target="_blank">FDA Advisory Panel Votes to Loosen Rules on BPC-157, TB-500, and MOTS-C Despite Agency Scientists' Opposition</a>&nbsp;&nbsp;<font color="#6f6f6f">Medical Daily</font>

[Оригинал](https://www.medicaldaily.com/fda-panel-votes-bpc-157-tb-500-mots-c-compounding-pharmacies-2026-476330)